Journal of Medicinal Chemistry p. 5623 - 5642 (2018)
Update date:2022-08-15
Topics:
Wang, Feng
Jeon, Kyu Ok
Salovich, James M.
Macdonald, Jonathan D.
Alvarado, Joseph
Gogliotti, Rocco D.
Phan, Jason
Olejniczak, Edward T.
Sun, Qi
Wang, Shidong
Camper, Demarco
Yuh, Joannes P.
Shaw, J. Grace
Sai, Jiqing
Rossanese, Olivia W.
Tansey, William P.
Stauffer, Shaun R.
Fesik, Stephen W.
WDR5 is a chromatin-regulatory scaffold protein overexpressed in various cancers and a potential epigenetic drug target for the treatment of mixed-lineage leukemia. Here, we describe the discovery of potent and selective WDR5-WIN-site inhibitors using fragment-based methods and structure-based design. NMR-based screening of a large fragment library identified several chemically distinct hit series that bind to the WIN site within WDR5. Members of a 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole fragment class were expanded using a structure-based design approach to arrive at lead compounds with dissociation constants <10 nM and micromolar cellular activity against an AML-leukemia cell line. These compounds represent starting points for the discovery of clinically useful WDR5 inhibitors for the treatment of cancer.
View MoreSuzhou HeChuang Chemical Co.,Ltd.
Contact:+86-512-88800520
Address:No.9 Guanchao Rd,Changshu Advanced Materials Industy Park
Wuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Contact:+86-021-50792271
Address:Building 24A, 300 Chuantu Road, Chuansha, Pudong new area, Shanghai, China, 201202
Shanghai Massive Chemical Technology Co., Ltd.
website:http://www.massivechem.com/
Contact:+86 21 34943721
Address:Room 435, 4th floor, Building 9, No. 2568 Gudai Road,Minhang District, Shanghai,
Zhangjiagang Golden Reach Fine Chemical Co.,LTD.
Contact:+86-512-6585 6968
Address:Changfu Road, Dongsha Chemical Industry Park, Zhangjiagang City, Jiangsu Province, China
Doi:10.1007/BF00763697
(1986)Doi:10.1080/00397919608003762
(1996)Doi:10.1016/j.tet.2012.09.087
(2012)Doi:10.1021/acscatal.8b00923
(2018)Doi:10.1248/cpb.34.1950
(1986)Doi:10.1016/j.tet.2008.08.010
(2008)